A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA

This study is ongoing, but not recruiting participants.

Study NCT00006430. Last updated on June 23, 2005. Information provided by National Center for Research Resources (NCRR)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00006430

Locations


United States, North Carolina
	Duke University Medical Center
	Durham, North Carolina, United States, 27710

Sponsors and Collaborators

National Center for Research Resources (NCRR)

Duke University

Investigators


Principal Investigator:	Johannes Vieweg, M.D.	Duke University